ChemicalBook >> CAS DataBase List >>2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl-
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl-
- CAS No.
- 2647503-57-7
- Chemical Name:
- 2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl-
- Synonyms
- 2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl-
- CBNumber:
- CB712459413
- Molecular Formula:
- C24H31ClF2N6O2
- Molecular Weight:
- 508.99
- MDL Number:
- MOL File:
- 2647503-57-7.mol
Last updated:2025-04-18 09:52:34
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- Properties
| Boiling point | 640.1±65.0 °C(Predicted) |
|---|---|
| Density | 1.38±0.1 g/cm3(Predicted) |
| form | Solid |
| pka | 15.14±0.29(Predicted) |
| color | White to off-white |
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- Chemical Properties,Uses,Production
Uses
CCT369260 (compound 1) is an orally avtive B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity. CCT369260 (compound 1) exhibits an IC50 of 520 nM[1].
in vivo
CCT369260 (compound 1, 15 mg/kg, po, single dose) significantly inhibits BCL6 in OCI-Ly1 DLBCL xenograft model[1].
| Animal Model: | OCI-Ly1 DLBCL xenograft model (female SCID mice)[1]. |
| Dosage: | 15 mg/kg. |
| Administration: | PO, single dose. |
| Result: | Decreased the levels of BCL6 in the tumor observed up to 10 h after administration. |
| Animal Model: | Female Balb/C mice[1]. |
| Dosage: | 1 mg/kg iv and 5 mg/kg po (Pharmacokinetic Analysis). |
| Administration: | IV and PO |
| Result: | Demonstrated moderate clearance (CL 20 mL min?1 kg?1) with mean oral bioavailability of 54%. |
References
[1] Benjamin R Bellenie, et al. Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders. J Med Chem. 2020 Apr 23;63(8):4047-4068. DOI:10.1021/acs.jmedchem.9b02076
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- Preparation Products And Raw materials
Raw materials
Preparation Products
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl- Suppliers
Global( 5)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Aladdin Scientific | tp@aladdinsci.com | United States | 52923 | 58 | |
| Jilin Province Woda Biotechnology Co., Ltd. | 13504435624 | 1927928688@qq.com | China | 1615 | 58 |
| Shanghai?Medlife?Pharm-Tech?Co.,?Ltd | 021-59167510 18117107507 | vip@med-life.cn | China | 5002 | 58 |
| RD International Technology Co., Limited | 18024082417 | market@ubiochem.com | China | 9835 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29641 | 58 |
2H-Benzimidazol-2-one, 5-[[5-chloro-2-[(3R,5S)-4,4-difluoro-3,5-dimethyl-1-piperidinyl]-4-pyrimidinyl]amino]-1,3-dihydro-3-(3-hydroxy-3-methylbutyl)-1-methyl-
2647503-57-7
C24H31ClF2N6O2




